<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0012">
 <label>12</label>
 <element-citation publication-type="journal" id="sbref0012">
  <person-group person-group-type="author">
   <name>
    <surname>Srivastava</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Mason</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Wagena</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Cuende</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Weiss</surname>
    <given-names>DJ</given-names>
   </name>
   <name>
    <surname>Horwitz</surname>
    <given-names>EM</given-names>
   </name>
   <name>
    <surname>Dominici</surname>
    <given-names>M</given-names>
   </name>
  </person-group>
  <article-title>Part 1: defining unproven cellular therapies</article-title>
  <source>Cytotherapy</source>
  <volume>18</volume>
  <issue>1</issue>
  <year>2016</year>
  <fpage>117</fpage>
  <lpage>119</lpage>
  <pub-id pub-id-type="pmid">26719202</pub-id>
 </element-citation>
</ref>
